Taking Ozempic or Wegovy? New eye warning raises questions in UAE
· Cairo time
Dubai: A new US warning about a rare eye condition associated with popular diabetes and weight-loss medicines has raised fresh questions for UAE patients, as recent local research highlights gaps in medicine counselling and the need for more evidence on long-term safety.The US Food and Drug Administration (FDA) has ordered updated safety warnings for GLP-1 medicines, including Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and…
